Hugh Thomas
@hughthomas00.bsky.social
Deputy ed @lancetgastrohep - liver lover but fond of all things gastro. Former NatRevGastro. Commonly 🏃♂️ or 🚴. All nonsense entirely mine. Terminal convert from X.
The true benefit of ZOE Daily 30+ actually lies in the small pieces of metal and stones that some lucky customers get to consume
www.food.gov.uk/news-alerts/...
www.food.gov.uk/news-alerts/...
Waitrose recalls ZOE Daily 30+ 7 Day because of possible presence of small stones and small pieces of metal
www.food.gov.uk
December 20, 2024 at 2:01 PM
The true benefit of ZOE Daily 30+ actually lies in the small pieces of metal and stones that some lucky customers get to consume
www.food.gov.uk/news-alerts/...
www.food.gov.uk/news-alerts/...
What an entrance!
December 18, 2024 at 2:31 PM
What an entrance!
NB: palatability defined by sugar/fat content, not subjective rating - all diets were perceived to be similarly pleasant/filling
November 26, 2024 at 11:00 AM
NB: palatability defined by sugar/fat content, not subjective rating - all diets were perceived to be similarly pleasant/filling
No permissions for external viewers
November 20, 2024 at 5:06 PM
No permissions for external viewers
There's an awful lot more data to explore, of course.
Research impact assessment by citations alone is far too narrow, and biases 'impact' towards certain hot topics - here's hoping that being able to assess policy and now clinical guideline citations will even out the playing field!
Research impact assessment by citations alone is far too narrow, and biases 'impact' towards certain hot topics - here's hoping that being able to assess policy and now clinical guideline citations will even out the playing field!
November 20, 2024 at 10:31 AM
There's an awful lot more data to explore, of course.
Research impact assessment by citations alone is far too narrow, and biases 'impact' towards certain hot topics - here's hoping that being able to assess policy and now clinical guideline citations will even out the playing field!
Research impact assessment by citations alone is far too narrow, and biases 'impact' towards certain hot topics - here's hoping that being able to assess policy and now clinical guideline citations will even out the playing field!
I'm a big fan of the new longitudinal citation visualisation for all altmetric items - this has been around for a few months now, and it enables a much better snapshot of impact
November 20, 2024 at 10:31 AM
I'm a big fan of the new longitudinal citation visualisation for all altmetric items - this has been around for a few months now, and it enables a much better snapshot of impact
Which papers were cited quickest?
Unsurprisingly, this outcome is dominated by COVID papers.
This letter on preventing COVID-19 in decomp cirrhosis (doi.org/10.1016/S246... was cited 36 days publication by AFEF guidance on care of patients with liver disease dx.doi.org/10.1016/j.cl...
Unsurprisingly, this outcome is dominated by COVID papers.
This letter on preventing COVID-19 in decomp cirrhosis (doi.org/10.1016/S246... was cited 36 days publication by AFEF guidance on care of patients with liver disease dx.doi.org/10.1016/j.cl...
November 20, 2024 at 10:31 AM
Which papers were cited quickest?
Unsurprisingly, this outcome is dominated by COVID papers.
This letter on preventing COVID-19 in decomp cirrhosis (doi.org/10.1016/S246... was cited 36 days publication by AFEF guidance on care of patients with liver disease dx.doi.org/10.1016/j.cl...
Unsurprisingly, this outcome is dominated by COVID papers.
This letter on preventing COVID-19 in decomp cirrhosis (doi.org/10.1016/S246... was cited 36 days publication by AFEF guidance on care of patients with liver disease dx.doi.org/10.1016/j.cl...